Log In | Register
More than 90 percent of researchers who have published studies favorable to the controversial diabetes drug Avandia had a financial stake in the issue, according to a study conducted by researchers from the Mayo Clinic.
90 percent of scientists backing Avandia diabetes drug had financial ties to drug companies
Seeded on Sat Jul 24, 2010 2:53 PM EDT
Article Source: Gulf human rights hero Thomas B. Manton falsely imprisoned, murdered- Enjoy this article? Help vote it up the 'Vine.
- Public Discussion (4)
Maybe the 90 percent should be taking Avandia...problem solved.
- 2 votes
#1 - Sat Jul 24, 2010 2:54 PM EDTCliff Rosen, MD, director, Maine Center for Osteoporosis Research and Education, University of Maine, Orono reported having received consulting, lecture or grant support as follows:
Black: Roche, Merck, Novartis and NPS Pharmacueticals. Bilezekian: NPS Pharmaceuticals, Merck, Eli Lilly Aventis, and the Alliance for Better Bone Health. Ensrud: Pfizer, Eli Lilly and NPS Pharamceuticals. Greenspan: Merck, NPS Pharmaceuticals, Novartis and Aventis. Lang: Amgen, Aventis, Kaiser Permanente, NPS Pharmaceuticals and Aventis, and also holds stock in GlaxoSmithKline, Pfizer and Merck. Rosen: Quintiles Canada, Wyeth-Ayerst, Novartis, Merck, Eli Lilly and Aventis.
http://www.sciencedaily.com/releases/2005/08/050811084705.htm
Endocrinologist Reflects on Rosiglitazone:
As the FDA processes the vote and discussion from last week's advisory committee meeting on rosiglitazone (Avandia), Cliff Rosen, MD an endocrinologist who has twice voted to keep the diabetes drug on the market dissected what the recent vote meant in a Perspective published in the New England Journal of Medicine.
Rosen, a stock holder of GalxoSmithKline, chaired the FDA advisory committee that, in 2007, voted that while the drug appears to carry a higher risk of cardiovascular events, it should continue to be marketed.
"Rosen reported he has no conflicts of interest."
http://www.medpagetoday.com/Cardiology/Diabetes/21332?utm_content=&utm_medium=email&impressionId=&utm_campaign=DailyHeadlines&utm_source=&userid=
- 2 votes
#2 - Sat Jul 24, 2010 3:08 PM EDTMayo Clinic calling the kettle black?? Ethics??
Sorry, but this Mayo group has previously been deeply involved in the orthapedic scandal of Zimmer Holdings two years ago. Their devious income was about 4 million dollars. I did attempt to find 2009 and 2010 income directly paid to Mayo from Zimmer but the info was not readily available to gain.
Second, Mayo cancelled a much needed rail line to haul Wyoming low sulfur coal to Lake Michigan port. This would have improved our air quality and reduced the high asthma rate we now have in our children - from power plants.
Complained that noise would disturb their patients about 6 blocks away. NUTZ. I woulda been as quiet as a mouse.
I view Mayo as a hypocritical organization. Just as these so called scientists provide the test results they are paid to deliver, Mayo should not be allowed to be holier than thou when they would love the income AND may have sent out this press release to become part of the validation teams and enjoy the EZ money.
Lastly, they are first in line to charge high dollars for their services. If they wish to set a high standard, why do they not hold the line on prices charged? USA health care costs 17% of our annual work. Why do they not formulate a plan to reduce this to 4% and lead the way by their own actions.
- 1 vote
#3 - Sat Jul 24, 2010 9:45 PM EDTObviously...we have allot of liars in the industry.They forget their conflict of interest is screaming like a red blinking light on their forehead. Who do they think they are fooling?
- 1 vote
You're in Easy Mode. If you prefer, you can use XHTML Mode instead. |
As a new user, you may notice a few temporary content restrictions. Click here for more info.
